NCT00405964View on ClinicalTrials.gov

Study for the Treatment of Persistent Allergic Rhinitis With Desloratadine (Study P04684)

PHASE3CompletedINTERVENTIONAL
Enrollment

716

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Allergic Rhinitis
Interventions
DRUG

5-mg Desloratadine

5-mg Desloratadine tablet, once daily for 12 weeks

DRUG

Placebo tablet

Placebo tablet, once daily for 12 weeks

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00405964 - Study for the Treatment of Persistent Allergic Rhinitis With Desloratadine (Study P04684) | Biotech Hunter | Biotech Hunter